Literature DB >> 2200737

Casein kinase II enhances the DNA binding activity of serum response factor.

J R Manak1, N de Bisschop, R M Kris, R Prywes.   

Abstract

Serum response factor (SRF) is a mammalian transcription factor that binds to the serum response element in the enhancer of the c-fos proto-oncogene and thus may mediate serum-induction of c-fos transcription. We report here that the DNA binding activity of recombinant SRF made in Escherichia coli can be greatly enhanced by incubation of the protein with HeLa cell nuclear extract. The enhancing activity is ATP or GTP dependent and cofractionates with a protein kinase that phosphorylates SRF on a specific tryptic peptide. Coincubation with phosphatase blocks the enhancing activity, further suggesting that the enhanced binding activity is due to phosphorylation. The specific tryptic phosphopeptide phosphorylated in vitro is also phosphorylated in vivo, demonstrating that this phosphorylation is physiologically important. We have localized the phosphorylation site by a small deletion mutant. Finally, we show that the kinase activity is provided by casein kinase II (CKII) or a close variant. The potential role of CKII as either a regulatory or constitutive modifier of SRF in vivo will be discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2200737     DOI: 10.1101/gad.4.6.955

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  61 in total

1.  Interaction of ATF6 and serum response factor.

Authors:  C Zhu; F E Johansen; R Prywes
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  DNA binding activity of the Arabidopsis G-box binding factor GBF1 is stimulated by phosphorylation by casein kinase II from broccoli.

Authors:  L J Klimczak; U Schindler; A R Cashmore
Journal:  Plant Cell       Date:  1992-01       Impact factor: 11.277

3.  NF-AB, a liver-specific and cytokine-inducible nuclear factor that interacts with the interleukin-1 response element of the rat alpha 1-acid glycoprotein gene.

Authors:  K A Won; H Baumann
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

4.  The essential function for serum response factor in T-cell development reflects its specific coupling to extracellular signal-regulated kinase signaling.

Authors:  Anastasia Mylona; Robert Nicolas; Diane Maurice; Mathew Sargent; David Tuil; Dominique Daegelen; Richard Treisman; Patrick Costello
Journal:  Mol Cell Biol       Date:  2010-11-22       Impact factor: 4.272

5.  Serum response factor MADS box serine-162 phosphorylation switches proliferation and myogenic gene programs.

Authors:  Dinakar Iyer; David Chang; Joe Marx; Lei Wei; Eric N Olson; Michael S Parmacek; Ashok Balasubramanyam; Robert J Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

6.  p67SRF is a constitutive nuclear protein implicated in the modulation of genes required throughout the G1 period.

Authors:  C Gauthier-Rouvière; J C Cavadore; J M Blanchard; N J Lamb; A Fernandez
Journal:  Cell Regul       Date:  1991-07

7.  A novel nuclear inhibitor I-92 regulates DNA binding activity of octamer binding protein p92 during the cell cycle.

Authors:  J Weitz; M Kopun; M Stoehr; I Napierski; H D Royer
Journal:  Nucleic Acids Res       Date:  1991-10-25       Impact factor: 16.971

8.  Differential regulation of early response genes and cell proliferation through the human granulocyte macrophage colony-stimulating factor receptor: selective activation of the c-fos promoter by genistein.

Authors:  S Watanabe; A Muto; T Yokota; A Miyajima; K Arai
Journal:  Mol Biol Cell       Date:  1993-10       Impact factor: 4.138

9.  Phosphorylation negatively regulates the function of coactivator PC4.

Authors:  H Ge; Y Zhao; B T Chait; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

10.  PKA-dependent phosphorylation of serum response factor inhibits smooth muscle-specific gene expression.

Authors:  Alicia L Blaker; Joan M Taylor; Christopher P Mack
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-09-24       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.